Cordlife splurged RM29.58m in StemLife Berad interest acquisition
It acquired 19.8% stake.
According to OSK, Cordlife acquires interests in StemLife Berad. The multi-product healthcare company, Cordlife, announces its acquisition of 19.8% interest in StemLife Berhad for an aggregate consideration of RM29.58m.
Here's more:
StemLife is a Malaysian company, well-known for being the first cell stem and therapeutics company in the country.
Through StemLife and its associated company, Thai StemLife Co Ltd., Cordlife’s intend to benefit from the acquisition by expanding in Asia to Malaysia and Thailand.